Thoracic Oncology Laboratory »  Publications

Publications

View by Year:
 
Yagui-Beltran, A., He, B., & Jablons, D.M.
Exploiting the Human Immune System for Lung Cancer Therapy
U.S. Oncology, 2008;[In Press].
Wilson SM, Barbone D, Yang TM, Jablons DM, Bueno R, Sugarbaker DJ, Nishimura SL, Gordon GJ, Broaddus VC
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids.
American journal of respiratory cell and molecular biology, Nov-2008;39(5):576-83.  Epub 2008 May 29.
Yagui-Beltrán A, He B, Jablons DM
The role of cancer stem cells in neoplasia of the lung: past, present and future.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, Nov-2008;10(11):719-25.
To MD, Wong CE, Karnezis AN, Del Rosario R, Di Lauro R, Balmain A
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
Nature genetics, Oct-2008;40(10):1240-4.  Epub 2008 Aug 31.
Okamoto J, Mikami I, Tominaga Y, Kuchenbecker KM, Lin YC, Bravo DT, Clement G, Yagui-Beltran A, Ray MR, Koizumi K, He B, Jablons DM
Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Oct-2008;3(10):1089-95.
Raz DJ, Ray MR, Kim JY, He B, Taron M, Skrzypski M, Segal M, Gandara DR, Rosell R, Jablons DM
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research, Sep-1-2008;14(17):5565-70.
Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M, Massuti B, Chaib I, Perez-Roca L, Jassem J, Rosell R
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research, Aug-1-2008;14(15):4794-9.
Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM
Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
Head & neck, Jul-2008;30(7):946-63.
You L, Xu Z, Punchihewa C, Jablons DM, Fujii N
Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor-mediated transcription.
Molecular cancer therapeutics, Jun-2008;7(6):1633-8.
Rosell R, de Las Peñas R, Balaña C, Santarpia M, Salazar F, de Aguirre I, Reguart N, Villa S, Wei J, Ramirez JL, Molina MA, Ramon y Cajal S, Jablons D, Taron M
Translational research in glioblastoma multiforme: molecular criteria for patient selection.
Future oncology (London, England), Apr-2008;4(2):219-28.
Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
Anticancer research, 2007 Nov-Dec;27(6B):4239-42.
Kim J, Raz D, Jablons D
Unmet need in lung cancer: can vaccines bridge the gap?
Clinical lung cancer, Feb-2008;9 Suppl 1:S6-12.
Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D
Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
Cancer science, Jan-2008;99(1):46-53.  Epub 2007 Nov 13.
Reich J, Asaph J
Natural history of stage I lung cancer.
Chest, Dec-2007;132(6):2062; author reply 2062-3.
Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
Anticancer research, 2007 Nov-Dec;27(6B):4239-42.
[    1  2  3  4  5  6  7  8  9  10  11     View All ]
X